Delivers affordable pharmaceutical products in oncology, nephrology, general medicine, and veterinary care.
Annual revenue $115,773 Latest available
Total funding - Funding intelligence
Employees 15 Tracked headcount
Investors - Known backers
Products 4 Services tracked
Competitors - Brand Intelligence

About Biotexuspharma

Biotexuspharma is a company based in India. It operates as a B2B. The company has 15 employees as of March 31, 2022. Biotexuspharma offers products and services including Texcurmin 500 mg Capsule, Texfer 150 mg, Bioplate, and Figtex.

  • Headquarter India
  • Employees 15 as on 31 Mar, 2022
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Biotexus Pharmaceutical Pvt. Ltd.
  • Date of Incorporation 19 Aug, 2019
  • Jurisdiction Kolkata, West Bengal, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $115.77 K (USD)
    98.21
    as on Mar 31, 2022
  • Net Profit
    $2.13 K (USD)
    108.26
    as on Mar 31, 2022
  • EBITDA
    -$858.21 (USD)
    -136.52
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    15

    as on Mar 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biotexuspharma

Biotexuspharma offers a comprehensive portfolio of products and services, including Texcurmin 500 mg Capsule, Texfer 150 mg, Bioplate, and Figtex.

Product name locked
Category locked
Primary

Capsule used for cancer treatment and supportive care.

Product name locked
Category locked
Locked

Treatment for kidney-related health conditions.

Product name locked
Category locked
Locked

Supplement for general health and wellness support.

Product name locked
Category locked
Locked

Product for nutritional enhancement and daily health.

Funding Insights of Biotexuspharma

Premium access

Detailed funding history for Biotexuspharma

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Biotexuspharma

Investments
Premium access

Investment portfolio details for Biotexuspharma

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Biotexuspharma

Premium access

Detailed financials for Biotexuspharma

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Biotexuspharma Comparisons

Biotexuspharma Primary company
Description
Delivers affordable pharmaceutical products in oncology, nep...
Location
India
Founded Year
-
Annual Revenue
$115.77 K (USD)
Net Profit
$2.13 K (USD)
EBITDA
-$858.21 (USD)
Employees
15
As of 2022
Premium access

Peer comparison for Biotexuspharma

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Biotexuspharma

Premium access

Detailed competitors of Biotexuspharma

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Biotexuspharma

Premium access

Complete news archive for Biotexuspharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Biotexuspharma

Biotexuspharma is headquartered in India.

As of Mar 31, 2022, the latest employee count at Biotexuspharma is 15.

Annual revenue of Biotexuspharma is $115.77K as on Mar 31, 2022.

Biotexus Pharmaceutical is a healthcare organization focused on improving lives by offering affordable, high-quality products in oncology, nephrology, general medicine, veterinary care, and nutraceuticals. They emphasize innovation through RD and manufacturing, ensuring accessibility in rural and urban areas of India. Based primarily in Kolkata, they address unmet medical needs via a strong supply chain and partnerships.

Biotexuspharma offers Texcurmin 500 mg Capsule, Texfer 150 mg, Bioplate, and Figtex.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available